Marriott (MAR): The Credit Card Did The Work. Is MAR a Buy?

Marriott International, Inc. (MAR) Q2 2026 — Reported before the open August 3, 2026 (calendar Q2, quarter ended June 30). Adjusted diluted EPS $3.19 (+20.4%) vs a ~$3.08 consensus. Adjusted EBITDA $1,592M (+13%). But total revenues were $7,071M against a ~$7.19B Street number — a miss — and REPORTED operating income FELL 1% to $1,229M. The company raised full-year RevPAR growth to 3.0-3.5% and full-year adjusted EPS to $11.64-11.81, yet guided Q3 adjusted EPS to $2.74-2.82 against a ~$2.86 consensus and cut net rooms growth to the LOW END of 4.5-5%. The stock fell 6.8% to $347.33. The framing nobody applied: gross fee revenues grew 13%, but franchise fees grew 18.9% ($860M to $1,023M) on what Marriott itself calls 'primarily higher co-branded credit card fees', while BASE MANAGEMENT FEES — the purest hotel line in the P&L — grew 0.9% ($340M to $343M). Worldwide RevPAR was +3.4% and net rooms +4.5%. In May the outlook said in writing it 'does not include any impact from the renegotiation of our U.S. co-branded cards'; in August it 'includes the expected partial year incremental impact of the new terms' — and the full-year gross fee guide went up exactly $100M at both ends. Second unwritten line: cost reimbursement revenue of $5,058M against $5,100M of reimbursed expenses is MINUS $42M, against PLUS $58M a year ago, and adjusted EPS deletes both lines entirely. THE CALL: SELL (3/5, A GREAT BUSINESS, A CREDIT-CARD-FLATTERED QUARTER, AND A PRICE THAT NEEDS PERFECTION) — base-case value ~$245.0 vs ~$347.33 today. KEY METRICS: - CALL: SELL 3/5 — fair value ~$245 vs $347.33 (-29.5%). Owner-earnings DCF on FEE-based free cash flow. FY2026E FCF $2,900M (FY2025 actual: $3,212M operating cash flow less $604M capex = $2,608M, per SEC XBRL). Base case 10% for 5 years, 6% for 5 more, 3.0% terminal at 8.5%: PV yrs 1-5 $15,113M + yrs 6-10 $14,489M + terminal $51,769M = $81,371M EV, less $16,400M net debt, / 264.5M diluted shares = $246. Nine-cell grid (bear/base/bull x 8.0%/8.5%/10.0%): NOT ONE cell reaches $347.33 — the most generous, bull at 8%, is $338. Weighted 25/50/25 = $245. Reverse DCF: the price needs 14.5% FCF growth for five years and 8.7% for five more, or 4.8% terminal growth forever, or a 7.2% discount rate. Marriott has NEGATIVE book equity from a decade of buybacks, so no P/B framing is used. - THE CREDIT CARD DID THE WORK: gross fee revenues $1,578M (+13%), but franchise fees $860M to $1,023M (+18.9%) driven 'primarily by higher co-branded credit card fees', while base management fees went $340M to $343M (+0.9%) and incentive fees $200M to $212M (+6%). Worldwide RevPAR +3.4% (U.S. & Canada +5.0%, international -0.5%), net rooms +4.5%. The proof is in the guidance: May's outlook explicitly EXCLUDED the U.S. co-branded card renegotiation and guided FY gross fees to $5,925-5,985M; August's INCLUDES it and guides $6,025-6,055M — up exactly $100M at both ends. - THE LINE ADJUSTED EPS DELETES: cost reimbursement revenue $5,058M against reimbursed expenses $5,100M = MINUS $42M, versus $4,932M against $4,874M = PLUS $58M a year ago — a $100M swing. Six months: minus $134M vs minus $9M. Both lines are removed IN FULL to reach adjusted results, which is exactly why REPORTED operating income fell 1% ($1,236M to $1,229M) while ADJUSTED operating income rose 12% ($1,186M to $1,329M), and why reported EPS is $2.90 against an adjusted $3.19. Also in reported: a $68M impairment on a U.S. hotel sale (adjusted out) and a $27M property litigation accrual worth $0.08/share (not adjusted out). - THE RAISE IS PARTLY ARITHMETIC: adjusted net income +15.9% ($728M to $844M) but adjusted EPS +20.4% ($2.65 to $3.19) — diluted shares fell 3.7%, 274.7M to 264.5M. Marriott bought 3.0M shares for $1.1B in the quarter and 6.2M shares for $2.2B year-to-date, with FY capital return guided above $4,500M — about 4.9% of the $91.5B market value in one year. Total debt rose to $16.9B against $0.5B of cash. Three guide lines went the WRONG way: net rooms growth cut to the LOW END of 4.5-5%; owned/leased net cut $40M to $175-185M; investment spending raised $200M to $1,250-1,350M. And Q3 adjusted EPS is guided $2.74-2.82 against a ~$2.86 consensus. - THE HONEST OTHER SIDE, AND THE STREET: a record development pipeline of 4,186 properties and ~629,000 rooms (up nearly 7%, 44% under construction), record first-half global signings, Marriott Bonvoy past 295 million members, a 66% adjusted operating margin on $2,013M of adjusted revenue, and U.S. & Canada RevPAR +5.0% with company-operated luxury RevPAR $357.49 (+9.5%) and The Ritz-Carlton +9.8%. Street: Hold (23 buy / 28 hold / 1 sell, 52 analysts), average target $393.50, range $350-$449, implying +13.3%. We ALIGN on the business, DIFFER on price, and are far more CAUTIOUS. What to watch: Bullish: base management fees re-accelerating from 0.9% to mid single digits, which is the cleanest read on underlying hotel economics in the filing; the Middle East normalising off a 43% RevPAR decline, with over half the pipeline international; or evidence the JPMorgan Chase / American Express card repricing is a recurring escalator rather than a one-time step. Bearish: the November 3 print at the low end of the $2.74-2.82 guide with U.S. RevPAR decelerating below 4%; the reimbursement gap widening again beyond minus $42M; or net rooms growth slipping below 4.5%, the line already quietly cut to the low end of its range. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.